Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-017567

CBO & EVP sold 4,572 shares at $138.17 ($631,713)

  • CBO & EVP acquired 10,136 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kassberg Thomas Richard CBO & EVP 2021-03-01 Grant or award +5,500 106,978 D: show line 1 in the form
Kassberg Thomas Richard CBO & EVP 2021-03-01 Grant or award +4,636 111,614 D: show line 2 in the form
Kassberg Thomas Richard CBO & EVP 2021-03-01 Sale −4,572 $138.17 $631,713 107,181 D: show line 3 in the form
Open-market sales · 4,572 sh · avg $138.17 · $631,713

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kassberg Thomas Richard CBO & EVP 2021-03-01 Grant or award · Stock Option (Right to Buy) +11,000 11,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…